TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Treatment-emergent potentially clinically significant abnormalities in safety laboratory parameters: hematology
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-emergent potentially clinically significant abnormalities in safety laboratory parameters: serum chemistry
Endpoint domain: Adverse events/effects
Primary endpoint: number of steps taken daily after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance moved after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of the gastrointestinal system after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: level of ability to perform daily living activities after surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Severity of Side effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embryo fertilization and development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Area Under the Serum Concentration-time Curve (AUCinf) of Teprotumumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time 0 to the Last Quantifiable Concentration (AUClast) of Teprotumumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Teprotumumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Time Management Skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Errors using inhaler devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain-to-Brain Synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the drug concentration-time curve from time 0 to the last measurable concentration sample collection time t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac output responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Multiple Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BFS Vertical Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic Reaction Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Dentin Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oswestry Disability Index (ODI) percentage score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hsCRP (mg/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Parent reported Pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child reported pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-hour time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achilles tendon cross sectional-area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: women's fertility awareness scale average scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: women's preconceptional knowledge and attitude scale average scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of outcomes of completed antituberculosis treatment
Endpoint domain: Mortality/survival
Primary endpoint: Banff Patellofemoral Instability Instrument 2.0 change from pre- to postoperative score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Norwich patellar Instability score change from pre- to postoperative score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Detection of new clinically relevant findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate of normal to cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Conversion rate of cognitive impairment to dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Apixaban for TAH3311 Oral Dissolving Film (ODF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Apixaban for ELIQUIS® 5 mg Oral Tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration curve from time zero to last sampling time (AUC0-t) of Apixaban for TAH3311 Oral Dissolving Film (ODF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration curve from time zero to last sampling time (AUC0-t) of Apixaban for ELIQUIS® 5 mg Oral Tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events related to CD19 universal CAR-T cells
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Haemodynamic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Albumin/Globulin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in total serum protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in prealbumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant retention
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Child's Challenging Behaviour Scale 2 (CCBS-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent's Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immunotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Desire to die by suicide
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change on the Leaky gut biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of Inflammation biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum cross-linked C telopeptide of type I collagen (sCTX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Migraine Headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of non-hematologic serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: PrEP Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pancreas fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) of α-lactalbumin vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Anastomotic Leak
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Esophageal Stricture
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Requiring Ventilation >48 Hours
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Empyema
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Pulmonary Embolism
Endpoint domain: Adverse events/effects
Primary endpoint: CD155 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visuospatial pointing behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intracortical excitability [paired pulse transcranial Magnetic Stimulation (TMS)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in corticospinal excitability (single pulse TMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Coronal Facial Bone Maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the quality of life test
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 10-second Grip and Release test (GR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-second Stepping Test (SST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Tapping Test (FTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of interleukin 6 (IL-6) in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of ZL-1102
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression, Anxiety and Stress Scale (DASS) 21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posttraumatic Growth Index (PTGI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: WHO quality of life (WHOQOL)-bref
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Osteoarthritis Knee and Hip Quality of Life Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Flow-based overall response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in knee pain numerical rating scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related Quality of Life: Short Form-36 (SF36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Disability Level: measure of pelvic girdle questionnaire(PGQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pain intensity measure of Numeric Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants up-to-date for vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants at increased risk of vaccine-preventable diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with post-COVID-19 condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first day with ATA burden of 12 hours or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Cardiac output Index (CI) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Stroke Volume Index (SVI) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tumor enhancement in arterial phase (Hounsfield unit number)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic islet function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Time to biliary obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in LV stiffness constant (S+) at peak exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in serum levels of procollagen type I C-terminal propertied (PICP, ng/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of Antiretroviral (ARV) concentration in dried blood spot (DBS) samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported measure of care engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of Antiretroviral (ARV) medication in urine sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CD8 TILs density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: gross tumor volume (GTV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Angular deviations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in sedentary behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Initial successful puncture of the common femoral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CT visual Warrick score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Application-Site Event During Double-Blind Period
Endpoint domain: Adverse events/effects
Primary endpoint: baby's physical development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who agree to use Penny
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient engagement over time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device-Related Serious Adverse Event Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability via Credibility Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability via Client Satisfaction Questionnaire (CSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility via Client Satisfaction Questionnaire (CSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sensitivity of the HDQ for screening of patients with haemorrhoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of the HDQ for screening of patients with haemorrhoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chemoreflex function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical autonomic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Drug sensitivity profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental Attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dental visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bone Change Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe implantation of the SENSOR
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of device integration in the subcutaneous tissue
Endpoint domain: Adverse events/effects
Primary endpoint: SENSOR stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new health care actions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in physical activity facilitators and barriers
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fear avoidance beliefs related to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Motivation for participation in physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Agility assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to a heavy lifting strength training program
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of maximal strength testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance rates at 6-months intervals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients in each arm attending HCC surveillance regularly
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Satisfaction using the device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Workflow of the clinical procedure for dressing change
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: vMN geometric mean titre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total 24-hour movement behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Change From Baseline in TNSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight loss ≥10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative proportion of collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative proportion of lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative proportion of hemo/myoglobin signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioids dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observation Scale of Behavioral Distress (OSBD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in upper extremity active range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term pulmonary effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: long-term nutritional effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptability of the intervention by peer coaches and other health facility staff
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of peer coaching activities/orientation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Willingness to continue peer-coaching and clinical audit activities for PEN program implementation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Completion of diagnostic tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: arterial hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lung function evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participant attendance at PREHAB sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention of a removable partial denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: five year overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Platelet Fibrin Clot Formation (MA, mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Speed of Clot Formation (R, min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of months to recruit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correlation between the TOSL score and PAOFI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance use patterns following R2R access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health care utilization patterns following R2R access
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health among study participants over time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence, severity, and type of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical attachment level in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of the bone defect in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal Strain (GLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breastfeeding Assistance Clinical Readiness Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy scale in clinical performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total number of TB cases detected
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with hSBA titers at Day 91
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with hSBA titers before booster dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with hSBA titers 30 days after booster dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: complication of surgery
Endpoint domain: Adverse events/effects
Primary endpoint: overall survival (OS) rate
Endpoint domain: Mortality/survival
Primary endpoint: allograft survival (AS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes